Table 2.
First author (Ref) | Clear identification of study population | Clear definition of outcome and outcome assessment | Independent Assessment of outcome parameters | No selective loss during followup | Important confounders and/or prognostic factors indentified | Adjusted odds ratio (specific adjusters) |
---|---|---|---|---|---|---|
Marcus et al. [7] | Yes | Yes | Yes | Yes | Yes | 0.75 (age, gender) |
Go et al. [16] | Yes | Yes | Yes | Yes | Yes | Not provided |
Alonso et al. [17] | Yes | Yes | Yes | Yes | Yes | 0.59 (age, gender) |
Afzal et al. [18] | Yes | Yes | No | Yes | Yes | Not provided |
Ruo et al. [19] | Yes | Yes | Yes | Yes | Yes | 0.51 (age, gender, Comorbid conditions, medications) |
Winkelmayer et al. [20] | Yes | Yes | Yes | Yes | Yes | Not provided |
Upshaw Jr. [21] | Yes | Yes | Yes | Yes | Yes | Not provided |
Shen et al. [22] | Yes | Yes | Yes | Yes | Yes | 0.49 (age, gender) |
Smith et al. [23] | Yes | Yes | Yes | Yes | Yes | 0.64 (unclear) |
Lahiri et al. [24] | Yes | Yes | Yes | Yes | Yes | 0.54 (age, gender, comorbid conditions) |